Crystalline (r)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate, compositions and methods of use thereof
US-2026062384-A1 · Mar 5, 2026 · US
Tsou Nancy is listed as an inventor on 7 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Tsou Nancy |
| Total patents | 7 |
| First publication | Mar 26, 2020 |
| Latest publication | Mar 5, 2026 |
Publications ranked by popularity score, then publication date.
US-2026062384-A1 · Mar 5, 2026 · US
US-12410133-B2 · Sep 9, 2025 · US
US-2023382861-A1 · Nov 30, 2023 · US
US-11680046-B2 · Jun 20, 2023 · US
US-2021363105-A1 · Nov 25, 2021 · US
US-11053199-B2 · Jul 6, 2021 · US
US-2020095201-A1 · Mar 26, 2020 · US
Latest publications not already listed above.
No data yet.
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Celgene Corp | 7 |
| Lundbeck La Jolla Research Center Inc | 4 |
| Abide Therapeutics Inc | 3 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07B2200/13 | 7 |
| A61P35/00 | 7 |
| A61P1/00 | 7 |
| A61P25/22 | 7 |
| A61P25/00 | 7 |